Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Kevin Patrick Danahy

Chief Commercial Officer at Pulse Biosciences, Inc. (PLSE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.0M

Reported trades

Filed Stock Type Shares Price Value Since
Feb 23SEC PLSEPulse Biosciences, Inc. Sell Plan 5,00043,298 held (−10%) $23.64 $118K +127.6%
Feb 17SEC PLSEPulse Biosciences, Inc. Sell Plan 20,00043,298 held (−32%) $23.37 $467K +130.3%
Feb 17SEC PLSEPulse Biosciences, Inc. Sell Plan 20,00043,298 held (−32%) $23.53 $471K +128.7%
Feb 17SEC PLSEPulse Biosciences, Inc. Sell Plan 20,00043,298 held (−32%) $23.63 $473K +127.7%
Feb 11SEC PLSEPulse Biosciences, Inc. Sell Plan 20,00043,298 held (−32%) $21.45 $429K +150.9%
Feb 11SEC PLSEPulse Biosciences, Inc. Sell Plan 20,00043,298 held (−32%) $23.52 $470K +128.8%
Feb 11SEC PLSEPulse Biosciences, Inc. Sell Plan 20,00043,298 held (−32%) $25.20 $504K +113.5%
Oct 7SEC PLSEPulse Biosciences, Inc. Sell Plan 4,60043,298 held (−10%) $18.53 $85K +190.4%
  • Sell

    Chief Commercial Officer Kevin Patrick Danahy sold $118K of PLSE at $23.64 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Kevin Patrick Danahy sold $467K of PLSE at $23.37 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Kevin Patrick Danahy sold $471K of PLSE at $23.53 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Kevin Patrick Danahy sold $473K of PLSE at $23.63 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Kevin Patrick Danahy sold $429K of PLSE at $21.45 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Kevin Patrick Danahy sold $470K of PLSE at $23.52 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.